治疗心律失常的基因疗法:机制,方法和治疗应用
Paschalis Karakasis1, Panagiotis Theofilis2, Panayotis K Vlachakis2
1Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Medical sciences (Basel, Switzerland)
|August 22, 2025
概括
基因疗法为心律失常提供精确的治疗方法, 传递和基因编辑技术的进步显示出希望,尽管临床应用仍面临挑战.
科学领域:
- 心血管医学
- 分子生物学
- 遗传学
背景情况:
- 心律失常导致严重的发病率和死亡率.
- 目前治疗心律失常的方法往往是不够的.
- 基因疗法提供了一种针对心律失常基质的新方法.
研究的目的:
- 审查心律失常的基因治疗的机制性理由,治疗策略和输送平台.
- 综合基因方法的翻译潜力和挑战.
- 突出这一领域的创新应用和未来方向.
主要方法:
- 对遗传性和获得性心律失常的基因疗法的当前文献的综述.
- 综合各种基因策略 (沉默,替代,编辑) 的数据.
- 对传递平台 (病毒载体,mRNA,非病毒工具) 的进展进行分析.
主要成果:
- 基因疗法策略如基因特异性沉默,基因替代和CRISPR编辑显示了各种心律失常的转化潜力.
- 新的交付平台提高了具体性和安全性.
- 创新的应用包括生物起器和突变不可知疗法.
结论:
- 基因疗法通过直接解决潜在的分子和结构缺陷来治疗心律失常.
- 克服载体热带性,免疫反应和有效载荷限制方面的挑战对于临床翻译至关重要.
- 整合来自患者的细胞,计算模型和动物研究将加速基因疗法的临床应用.
相关概念视频
Mechanism of Cardiac Arrhythmias
1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K
Dysrhythmias VI: Management of Dysrhythmias
106
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
847
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
847
Disturbances in Heart Rhythm
1.2K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.2K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K


